Weight trajectories after last tirzepatide or semaglutide prescription across a federated health network - PubMed
4 hours ago
- #weight trajectories
- #GLP-1 receptor agonists
- #real-world evidence
- Two-thirds of 4,182 patients maintained stable weight or continued weight loss for 6 months after their last GLP-1RA prescription.
- In a subset of 300 patients, treatment discontinuation was documented in 40% around the last prescription, with 72% not showing weight regain.
- Exercise counseling was more common among patients with durable weight loss after stopping GLP-1RA compared to those with weight regain (26.2% vs. 14.7%).